EANS-Adhoc: november AG
Extraordinary Income From Extensive Debt Waiver
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Financial Consolidation
07.01.2010
Today, november AG (ISIN: DE000A0Z24E9) succeeded in negotiating another waiver of a substantial loan. On the one hand, one of the major shareholders waives his entitlement to the repayment of a shareholder´s loan of approx. EUR 1.2 mio versus november AG without anything in return. On the other hand, also another loan to the subsidiary PROGEN Biotechnik GmbH in the amount of TEUR 670 is paid off completely by a one-off payment of TEUR 360. Thus, short-term liabilities were reduced by a total of approx. EUR 1.9 mio. This loan waiver results in an extraordinary income of approx. EUR 1.5 mio, improving the equity base by this amount.
This constructive cooperation with the major shareholder represents another important milestone in the financial stabilization of the november AG and its subsidiaries.
end of announcement euro adhoc
Further inquiry note:
Dr. Dirk Zurek
CEO
Tel.: +49 (0) 221 82200 520 10
E-Mail: ir@november.de
Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade